The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Open accessAbstract
BACKGROUND: Patients generally die of cancer after the failure of current therapies to eliminate residual disease. A subpopulation of tumor cells, termed cancer stem cells (CSC), appears uniquely able to fuel the growth of phenotypically and histologically diverse tumors. It has been proposed, therefore, that failure to effectively treat cancer may in part be due to preferential resistance of these CSC to chemotherapeutic agents. The subpopulation of human colorectal tumor cells with an ESA(+)CD44(+) phenotype are uniquely responsible for tumorigenesis and have the capacity to generate heterogeneous tumors in a xenograft setting (i.e. CoCSC). We hypothesized that if non-tumorigenic cells are more susceptible to chemotherapeutic agents, then residual tumors might be expected to contain a higher frequency of CoCSC. METHODS AND FINDINGS: Xenogeneic tumors initiated with CoCSC were allowed to reach approximately 400 mm(3), at which point mice were randomized and chemotherapeutic regimens involving cyclophosphamide or Irinotecan were initiated. Data from individual tumor phenotypic analysis and serial transplants performed in limiting dilution show that residual tumors are enriched for cells with the CoCSC phenotype and have increased tumorigenic cell frequency. Moreover, the inherent ability of residual CoCSC to generate tumors appears preserved. Aldehyde dehydrogenase 1 gene expression and enzymatic activity are elevated in CoCSC and using an in vitro culture system that maintains CoCSC as demonstrated by serial transplants and lentiviral marking of single cell-derived clones, we further show that ALDH1 enzymatic activity is a major mediator of resistance to cyclophosphamide: a classical chemotherapeutic agent. CONCLUSIONS: CoCSC are enriched in colon tumors following chemotherapy and remain capable of rapidly regenerating tumors from which they originated. By focusing on the biology of CoCSC, major resistance mechanisms to specific chemotherapeutic agents can be attributed to specific genes, thereby suggesting avenues for improving cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Self-citationStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Self-citationGlioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Self-citationProspective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,820
Phenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
Self-citationThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Unlike in normal development, however, neoplastic progenitor cell populations can gain self-renewal capabilities, thereby also fulfilling the definition of a CSC [2, 3 ].”
BackgroundIdentification of cells initiating human melanomas
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,415
Molecular Definition of Breast Tumor Heterogeneity
Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.013 · Cited by 1,353
A distinct “side population” of cells with high drug efflux capacity in human tumor cells
Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., Goodell, M. A., & Brenner, M. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400067101 · Cited by 1,280
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells
Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3557 · Cited by 947
Stem Cells and Cancer: Two Faces of Eve
Clarke, M. F., & Fuller, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.011 · Cited by 905
Self-citationPatrawala, L., Calhoun, T., Schneider-Broussard, R., Zhou, J., Claypool, K., & Tang, D. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0592 · Cited by 903
Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells
Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L., & Strasser, A. (2007) · Science · doi:10.1126/science.1142596 · Cited by 827
Myc deletion rescues Apc deficiency in the small intestine
Sansom, O. J., Meniel, V. S., Muncan, V., Phesse, T. J., Wilkins, J. A., Reed, K. R., Vass, J. K., Athineos, D., Clevers, H., & Clarke, A. R. (2007) · Nature · doi:10.1038/nature05674 · Cited by 613
Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis
Donnenberg, V. S., & Donnenberg, A. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005276905 · Cited by 457
Hess, D. A., Meyerrose, T. E., Wirthlin, L., Craft, T. P., Herrbrich, P. E., Creer, M. H., & Nolta, J. A. (2004) · Blood · doi:10.1182/blood-2004-02-0448 · Cited by 351
Retinoids in cancer therapy and chemoprevention: Promise meets resistance
Freemantle, S. J., Spinella, M. J., & Dmitrovsky, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206936 · Cited by 312
Role of Human Aldehyde Dehydrogenases in Endobiotic and Xenobiotic Metabolism
Vasiliou, V., Pappa, A., & Estey, T. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120034001 · Cited by 308
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
Weichert, W., Knösel, T., Bellach, J., Dietel, M., & Kristiansen, G. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.016238 · Cited by 264
Rapid Loss of Intestinal Crypts upon Conditional Deletion of the Wnt/Tcf-4 Target Gene c-Myc
Muncan, V., Sansom, O. J., Tertoolen, L., Phesse, T. J., Begthel, H., Sancho, E., Cole, A. M., Gregorieff, A., de Alboran, I. M., Clevers, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00821-06 · Cited by 248
Breast cancer resistance protein (BCRP/ABCG2)
Staud, F., & Pavek, P. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.11.004 · Cited by 232
Sládek, N. E., Kollander, R., Sreerama, L., & Kiang, D. T. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0412-4 · Cited by 212
Metabolism and Transport of Oxazaphosphorines and the Clinical Implications
Zhang, J., Tian, Q., Yung Chan, S., Chuen Li, S., Zhou, S., Duan, W., & Zhu, Y.-Z. (2005) · Drug Metabolism Reviews · doi:10.1080/03602530500364023 · Cited by 189
Dangles-Marie, V., Pocard, M., Richon, S., Weiswald, L.-B., Assayag, F., Saulnier, P., Judde, J.-G., Janneau, J.-L., Auger, N., Validire, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0594 · Cited by 175
Nolta, J. A., Dao, M. A., Wells, S., Smogorzewska, E. M., & Kohn, D. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2414 · Cited by 169
Bettess, M. D., Dubois, N. C., Murphy, M., Dubey, C., Roger, C., Robine, S., & Trumpp, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7868-7878.2005 · Cited by 152
Moreb, J. S., Muhoczy, D., Ostmark, B., & Zucali, J. R. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0233-6 · Cited by 135
c-Myb is required for progenitor cell homeostasis in colonic crypts
Malaterre, J., Carpinelli, M. R., Ernst, M., Alexander, W. S., Cooke, M. P., Sutton, S. E., Dworkin, S., Heath, J. K., Frampton, J., McArthur, G. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610055104 · Cited by 113
Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells"
Kennedy, J. A., Barabé, F., Poeppl, A. G., Wang, J. C. Y., & Dick, J. E. (2007) · Science · doi:10.1126/science.1149590 · Cited by 112
Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines.
Sládek, N. E. (1999) · PubMed · Cited by 107
Aldehyde Dehydrogenase-Mediated Cellular Relative Insensitivity to the Oxazaphosphorines1
Sládek, N. E. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230110215319 · Cited by 105
Moreb, J. S., Gabr, A., Vartikar, G. R., Gowda, S., Zucali, J. R., & Mohuczy, D. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072496 · Cited by 93
Corti, S. P., Locatelli, F., Papadimitriou, D. A., Donadoni, C., Bo, R. D., Crimi, M., Bordoni, A., Fortunato, F., Strazzer, S., Menozzi, G., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi446 · Cited by 92
Strategies to eliminate cancer stem cells: Clinical implications
Huff, C. A., Matsui, W. H., Smith, B. D., & Jones, R. J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.045 · Cited by 58
Bates, R. C., Pursell, B. M., & Mercurio, A. M. (2007) · Cells Tissues Organs · doi:10.1159/000101300 · Cited by 48
Acute promyelocytic leukemia as a paradigm for targeted therapy
Tallman, M. S. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.02.004 · Cited by 47
Breast Cancer Stem Cells: A Case of Mistaken Identity?
Polyák, K. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0020-8 · Cited by 32
Effect of 4‐(Diethylamino)benzaldehyde on Ethanol Metabolism in Mice
Mahmoud, M. I. E., Potter, J. J., Colvin, O. M., Hilton, J., & Mezey, E. (1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb05233.x · Cited by 31
Research works printed but not linked: 6
- SE Kern, 2007, The fuzzy math of solid tumor stem cells: a perspective., Cancer Res, 67, 8985, 10.1158/0008-5472.CAN-07-1971 · doi:10.1158/0008-5472.can-07-1971
- AV Boddy, 2000, Metabolism and pharmacokinetics of oxazaphosphorines., Clin Pharmacokinet, 38, 291, 10.2165/00003088-200038040-00001 · doi:10.2165/00003088-200038040-00001
- P Fallon, 2003, Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation., Br J Haematol, 122, 99, 10.1046/j.1365-2141.2003.04357.x · doi:10.1046/j.1365-2141.2003.04357.x
- JE Russo, 1997, Inhibition of mouse and human class 1 aldehyde dehydrogenase by 4-(N,N-dialkylamino)benzaldehyde compounds., Adv Exp Med Biol, 414, 217, 10.1007/978-1-4615-5871-2_25 · doi:10.1007/978-1-4615-5871-2_25
- JE Russo, 1989, The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide., Prog Clin Biol Res, 290, 65
- MA Thompson, 1998, c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression., Cancer Res, 58, 5168
Cited by
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Fields, J. Z., Wicha, M. S., & Boman, B. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4418 · Cited by 1,045
Stem cell gene expression programs influence clinical outcome in human leukemia
Eppert, K., Takenaka, K., Lechman, E. R., Waldron, L., Nilsson, B., van Galen, P., Metzeler, K. H., Poeppl, A., Ling, V., Beyene, J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2415 · Cited by 1,041
Cancer stem cells as key drivers of tumour progression
Ayob, A. Z., & Ramasamy, T. S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0426-4 · Cited by 910
Metadata
- Authors
- Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., Clarke, M. F., Hoey, T., Lewicki, J., & Gurney, A. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-06-18
- Volume
- 3
- Issue
- 6
- Pages
- e2428
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2069831652
- Cited by
- 589
- References
- 44
- FWCI
- 22.18
- Type
- journal article
- Language
- en
- Update notices
- correction (2008-08-21)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.